baber/WOPTO huggingface dataset:
Patent AU-1252195-A (AU)
Title: Method of selecting specific bacteriophages
Inventor: BORREBAECK CARL A K
IPC: C12P21/04
Filed: 1994-12-05
Abstract: PCT No. PCT/SE94/01166 Sec. 371 Date Oct. 7, 1996 Sec. 102(e) Date Oct. 7, 1996 PCT Filed Dec. 5, 1994 PCT Pub. No. WO95/16027 PCT Pub. Date Jun. 15, 1995A method for selecting a molecule such as an antibody, antigen, peptide, protein or fragment thereof, which molecule is expressed together with a phage coat protein on the phage's surface. The method is characterised by linking phage replication to recognition of the molecule on the surface of the phage. The linkage can be achieved by use of a fusion protein between phage protein 3 and a specific binding ligand for the molecule.
Patent AU-1400697-A (AU)
Title: Method for processing a sample
Inventor: BANK PETRUS CORNELIS
IPC: G01N1/44
Filed: 1997-01-07
Abstract: PCT No. PCT/NL97/00005 Sec. 371 Date Oct. 20, 1998 Sec. 102(e) Date Oct. 20, 1998 PCT Filed Jan. 7, 1997 PCT Pub. No. WO97/26064 PCT Pub. Date Jul. 24, 1997A method for processing samples in a sealable container which is transparent to electromagnetic radiation, includes a) the sample and a polar non-solid medium being introduced into the container, b) the container being placed in a vessel which is transparent to electromagnetic radiation and which is filled with a nonpolar coolant which is transparent to electromagnetic radiation, and c) the vessel being irradiated with electromagnetic radiation, the temperature of the coolant being maintained lower than 5 DEG  C. and a vessel being used which is provided with an insulating material which is transparent to electromagnetic radiation.
Patent AU-1496099-A (AU)
Title: Vaccines containing attenuated bacteria
Inventor: CHATFIELD STEVEN NEVILLE
IPC: C12N15/01
Filed: 1998-12-10
Abstract: The invention relates to a vaccine comprising a bacterium attenuated by a non-reverting mutation in a gene encoding a protein which promotes folding of extracytoplasmic proteins. Such mutations were intially identified as being useful in vaccines from a bank of randomly inserted, transposon mutants in which attenuation was determined as a reduction in virulence of the organism in the mouse model of infection. Site directed mutation of the gene results in a strain which shows at least 4 logs of attenuation when delivered both orally and intravenously. Animals vaccinated with such a strain are protected against subsequent challenge with the parent wild type strain. Finally, heterologous antigens such as the non-toxic and protective, binding domain from tetanus toxin, fragment C, can be delivered via the mucosal immune system using such strains of bacteria. This results in the induction of a fully protective immune response to subsequent challenge with native tetanus toxin.
Patent AU-1550201-A (AU)
Title: Process for the production of sulfonic esters
Inventor: KANO FUMIHIKO
IPC: C07D211/40
Filed: 2000-11-24
Abstract: Sulfonic acid ester derivatives represented by the general formula (4) or (5) are produced by reacting an amino alcohol derivative represented by the general formula (1) or (2) with an organic sulfonyl halide represented by the general formula (3), in a mixed solvent composed of an aprotic organic solvent and water in the presence of a non -water-prohibiting inorganic base. This procedure can be carried out in a simple, easy, safe and economical manner while reducing the load on the environment. <CHEM> Wherein n represents an integer of 0 to 5, A represents a phenyl group, which may be substituted, R represents a methanesulfonyl, ethanesulfonyl, p-toluenesulfonyl or p-nitrobenzenesulfonyl group and X represents a chloride, bromine or iodine atom.
Patent AU-1631802-A (AU)
Title: Controlled self-oscillation modulator and power conversion system using such a modulator
Inventor: NIELSEN KARSTEN
IPC: H02M3/00
Filed: 2001-09-19
Abstract: A controlled oscillation modulator includes a comparator and a power amplification stage for pulse modulation, and a higher order oscillating loop comprising first feedback means (21) and first forward means (22) securing stable oscillating conditions. The modulator is characterized by current measurement means, arranged to measure a value (iL) of a current supplied by said power amplification stage to a load (5) connected to the modulator, said measured value being supplied to said first feedback means (21) has a transfer function adapted to generate said first feedback signal based on said measured value (iL), and said first forward means (21) has a transfer function adapted to generate said modulating signal based on said first feedback means and an input signal (Vi). Application are general DC-DC and DC-AC power conversion with inductive loading. In a preferred emplements a precision transconductance amplifier by a current feedback. In a futher preferred embodiment the controlled oscillation modulator implements a precision voltage power amplifier for audio amplification purposes.
Patent AU-1670599-A (AU)
Title: A container for foodstuffs
Inventor: RICHARDSON SEAN ANTHONY
IPC: B65D47/08
Filed: 1998-11-11
Abstract: The invention provides a container (2) with a container shroud (1) which has a base (4) and a top (3) and at least the top (3) is made of plastic and has a reclosable discharge aperture (23), with the top (3) having a lower circumferential edge (26) to connect the top (3) with the container shroud (1), and the discharge aperture (23) being covered by a cap (24) which is connected to the top (3) by film hinge (25) located in the vicinity of the highest point on the top (3) characterised in that the top (3) is substantially convex in form and the cap (24) is substantially concave in form and wherein the cap when in it's open form can be laid against the top (3) and in this state the cap (24) is largely congruent with the surface of the top (3). The container (2) has particular application in the packaging of foodstuffs.
Patent AU-1685883-A (AU)
Title: Platinum-anti-tumor immunoglobulin complexes
Inventor: ARNON RUTH
IPC: A61K47/48
Filed: 1983-07-14
Abstract: There are provided anti-tumor agents comprising as active ingredient platinum complexed directly or via dextranamine moieties to an anti-tumor immunoglobulin. These are prepared by reacting an anti-tumor immunoglobulin or such immunoglobulin coupled to a dextran-amine with a platinum salt. Immunoglobulins having a specific binding activity towards certain types of cancer cells can be used. Immunoglobulins specific for ovarian or testicular carcinoma or for renal adenocarcinoma complexed directly or via dextranamine moieties with platinum are effective agents for the treatment of these malignancies.
Patent AU-1704699-A (AU)
Title: Cutting board for food products and method of fabricating same
Inventor: HEATH DEREK E
IPC: A47J47/00
Filed: 1998-11-25
Abstract: A cutting board for cutting food products which is composed of a plurality of abrasive inserts arranged in parallel rows. In use, the knife blade is drawn along the channel formed between the adjacent rows, and the contact between the knife blade and the abrasive inserts acts to sharpen the knife blade on both of its sides.
Patent AU-1721797-A (AU)
Title: Process for determining the phototoxicity and/or photosensitivity of substances or mixtures thereof, and use thereof
Inventor: NEUMANN ROBERT J
IPC: G01N33/50
Filed: 1997-02-05
Abstract: A process is disclosed for determining the phototoxicity and/or photosensitivity of substances or substance mixtures, involving putting the chemical substance or substance mixture into contact with a non-human vertebrate embryo or tissues or tissue components of a vertebrate embryo, except for human skin cell cultures, whereby, following the contact, there is also a treatment with electromagnetic radiation ranging from 1 mm to 200 nm, followed by evaluation of the pathology of the embryo, tissue or cell; also disclosed is the use of a non-human vertebrate embryo or tissues or tissue components of such an embryo, except for human cell cultures, for purposes of determining the phototoxicity and/or photosensitivity of chemical substances/substance mixtures.
Patent AU-1785200-A (AU)
Title: Method for storing digital audio and video dataflow, storage device and receiver for implementing said method
Inventor: ROUX JEAN LE
IPC: H04N5/44
Filed: 1999-12-22
Abstract: The invention concerns a device for digital video reception comprising: means for receiving (101, 102, 103) and demultiplexing (113) audio and video packets from a multiplexed dataflow; a first video write memory (205) for accumulating a predetermined quantity of demultiplexed video packets; a second audio write memory (205b) for accumulating demultiplexed audio packets; means for storing (201) multiplexed audio and video packets in the form of blocks, each block comprising a first zone for recording video packets of fixed size equal to the predetermined quantity, and a second zone for recording audio packets of fixed size such that it is not less than the maximum quantity of audio data capable of being accumulated while the predetermined quantity of video data are being received. The invention also concerns a recording method and a recording device.
Patent AU-1858801-A (AU)
Title: Dimeric light stabilizers for polyolefins and polyolefin copolymers
Inventor: LEPPARD DAVID GEORGE
IPC: C07C45/71
Filed: 2000-11-21
Abstract: Compositions comprisingA) a polyolefin or polyolefin copolymer, andB) a compound of the formula IwhereinR1 is O or O-X-O;R2, R3, R4 and R5 independently are hydrogen, halogen, C1-C8alkyl, C1-C8alkoxy, SR10,SO2R10, phenyl, CF3, COOR11; and wherein R2 and R3 also may be OH;R6 and R7 are H or C1-C8alkyl;R8 and R9 are H, C1-C8alkyl or allyl;R10 is phenyl or C1-C12alkyl;R11 is C1-C8alkyl; C3-C50alkylene interrupted by one or more O; cyclohexyl; benzyl; allyl;X is C2-C18alkylene; C3-C12hydroxyalkylene; or a group selected from those of the formulaewhere D and D' independently are a direct bond or C1-C3alkylene; andY is O, S, SO2, or C1-C3alkylene, e.g. polyethylene films, are well stabilized against the effects of light, oxygen and heat. Some novel compounds of component B are valuable stabilizers for organic material against damage by light, oxygen and/or heat.
Patent AU-2207197-A (AU)
Title: Targeted site specific drug delivery compositions and method of use
Inventor: PORTER THOMAS R
IPC: C12N15/113
Filed: 1997-03-12
Abstract: The invention relates to a new and improved pharmaceutical composition and method for delivery of therapeutic agents. The methods and composition of the invention can be used with several therapeutic agents and can achieve site specific delivery of a therapeutic substance. This can allow for lower doses and for improved efficacy with drugs which traditionally reach targeted sites and can result in utility for agents such as oligonucleotides which are plagued with problems in reaching targeted sites in necessary therapeutic levels.
Patent AU-2290488-A (AU)
Title: Tap hole plugs for metallurgical vessels
Inventor: KOMANECKY RICHARD JAMES
IPC: C21C5/46
Filed: 1988-09-28
Abstract: A plug for the tap hole (H) of a metallurgical vessel (V) is formed by inserting in the hole (H), a container (10) having a fixed end wall (12) and a movable end wall (14), the container (10) housing a bag (27) containing a refractory mortar (26), an aperture (34) being present between the fixed wall (12) and the serrated edge (32) of a housing wall (30). The container (10) is diametrically smaller than the hole (H) so that an annular clearance is present. When the movable wall (14) is urged towards the fixed wall (12), the bag (27) is ruptured and the mortar (26) egresses into the annular clearance to form the plug. The container (10) is inserted at the end of a plunger (50) arranged to hold the container (10) and actuable to move the movable wall (14).
Patent AU-2375392-A (AU)
Title: Syringe system
IPC: A61K38/28
Filed: 1992-07-02
Abstract: An insulin injection system comprises a pen shaped syringe with a cartridge containing insulin, and an injection needle, the needle is a thinner than G 29 needle and the insulin is a type which may freely flow through a thinner than G 29 needle. When the insulin is the type comprising suspended crystals the maximal dimension of any crystal is 15  mu m.
Patent AU-2470895-A (AU)
Title: System and method for automatically feeding, inspecting and diverting tablets for continuous filling of tablet containers
Inventor: ARCHER JOHN R
IPC: B07C5/10
Filed: 1995-05-05
Abstract: A system and method for automatically feeding, inspecting and diverting tablets for continuous filling of tablet containers includes a tablet conveyor system which divides the tablets in a plurality of tablet streams for inspection by color, size and shape. Following the tablet inspection, each tablet passes through a tablet diverter which diverts the tablets to a recycle stream, reject stream or one of two bottle filling positions based upon instruction from the inspection. A bottle conveyor system is provided which feeds empty bottles into a bottle escapement mechanism which positions the empty bottles for filling. Filled bottles are moved from the bottle escapement mechanism to an exit conveyor. The entire system is computer controlled by various control mechanisms to enable the system to be fully operational without operator assistance.
Patent AU-2513701-A (AU)
Title: Method for producing heterocyclic compounds
Inventor: SEIFERT HERMANN
IPC: C07D417/06
Filed: 2001-01-08
Abstract: The present invention relates to a process for the preparation of compounds of the formula (I)in which R<1>, A, D, X and Z have the meanings given in the description,by reacting compounds of the formula (II)in whichA, D and X have the meanings given above,with a base and in the presence of a diluent, and subsequently reacting the reaction mixture with the mixture of CCMP/CMP (2-chloro-5-chloromethylpyridine/2-chloro-5-methylpyridine) and the corresponding hydrochlorides.
Patent AU-2545497-A (AU)
Title: Temporary wet strength polymers from oxidized reaction product of polyhydroxy polymer and 1,2-disubstituted carboxylic alkene
Inventor: SMITH DAVID JAY
IPC: D21H19/10
Filed: 1997-03-25
Abstract: A temporary wet strength polymer and compositions for paper products, e.g., toilet tissue, is disclosed. The temporary wet strength polymer is the oxidation product of an esterified polyhydroxy polymer, more preferably of an esterified polysaccharide. The esterified polymer compound is formed by reacting the polyhydroxy polymer with a 1,2-disubstituted alkene compound that has at least one carboxylic acid group. The temporary wet strength polymer provides paper products having an initial wet strength that enables use of the product in the moistened condition, along with a suitable wet strength decay rate.
Patent AU-2641897-A (AU)
Title: Glass for tasting alcohols such as brandies, spirits and liqueurs
Inventor: DUBOIS AIME
IPC: A47G19/22
Filed: 1997-04-11
Abstract: A snifter for alcoholic beverages such as brandy, spirits and liquors including a glass having a softly flared container (1), with a bowl (2) extending therefrom and including two parts, a first lower part (20) flaring more sharply, extended by a second, higher part (21) gradually tapering up to the drinking lip (22), the opening of the latter defining a surface equal to or larger than that defined by the upper edge (10) of the container (1), which is the recommended filling limit.
Patent AU-2713295-A (AU)
Title: Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide
Inventor: MARUTA KAZUHIKO
IPC: C12N15/00
Filed: 1995-07-21
Abstract: Disclosed is a recombinant thermostable enzyme which has a molecular weight of about 69,000-79,000 daltons and a pI of about 5.4-6.4, and forms non-reducing saccharides having a trehalose structure as an end unit from reducing amylaceous saccharides having a degree of glucose polymerization of at least 3. The enzyme has satisfactorily high thermostability, i.e. it is substantially not inactivated even when incubated in an aqueous solution (pH 7.0) at 85 DEG C for 60 min, and this facilitates the production of such non-reducing saccharides on an industrial scale and in a satisfactorily-high yield.
Patent AU-2828400-A (AU)
Title: Liquid treatment device with storage tank and delivery tank
Inventor: YAMAGATA YUTAKA
IPC: G05D9/12
Filed: 2000-03-03
Abstract: In a liquid treating equipment to maintain a small amount of liquid to a desired liquid level with constantly supplying an additional liquid into a small capacity vessel, a storage vessel 13 to store the small amount of liquid, an injection tube 16 to inject the small amount of liquid into the storage vessel 16, liquid supplying apparatus 23-25 to supply the small amount of liquid into the storage vessel through the injection tube, a flow path 15 of which one end is joined with the storage vessel, a discharge vessel 14, joined with the storage vessel 13 via the flow path, having a larger surface area than that of the storage vessel, a discharge tube 17 of which the discharging inlet is positioned at the same level position as a desired liquid level of the small amount of liquid in the storage vessel and liquid discharging apparatus 27-29 to discharge the liquid from the discharge vessel through the discharge tube are provided. Even though the liquid level in the discharge vessel is largely fluctuated, the liquid level in the storage vessel is almost never done. <IMAGE>
Patent AU-2841099-A (AU)
Title: Method for preparing a biomaterial based on hydroxyapatite, resulting biomaterial and surgical or dental use
Inventor: LACOUT JEAN-LOUIS
IPC: A61K6/838
Filed: 1999-03-17
Abstract: A solid powder product with a Ca/P ratio of between 1.40 and 1.90 is prepared from tricalcium phosphate and tetracalcium phosphate. An aqueous solution containing calcium ions and phosphate ions with a Ca/P ratio higher than 0.20 and lower than 0.50 is prepared. The aqueous solution and the solid powder product and optionally water are mixed to obtain a mixture with a liquid/solid weight ratio of between 0.30 and 0.65 and a resulting paste with a Ca/P ratio of between 1.50 and 1.67.
Patent AU-2907684-A (AU)
Title: Beta-lactamase inhibiting 6-(alkoxyaminomethyl) penicillanic acid 1,1-dioxide and derivatives thereof
Inventor: PIRIE DONALD KLEIN
IPC: C07D499/00
Filed: 1984-06-05
Abstract: 6-alpha/beta-[(C1-C4)Alkoxyaminomethyl and benzyloxyaminomethyl]penicillanic acid 1,1-dioxides, pharmaceutically acceptable salts thereof and conventional esters thereof hydrolyzable under physiological conditions, all of which are useful in medicine as beta-lactamase inhibitors; intermediates and processes therefor; and a process for the conversion of the present compounds to 6-alpha- and 6-beta-(aminomethyl)penicillanic acid 1,1-dioxides and derivatives.
Patent AU-3257397-A (AU)
Title: Antifungal compositions
Inventor: BEUDEKER ROBERT FRANCISCUS
IPC: A01N63/50
Filed: 1997-06-09
Abstract: The invention provides synergistic combinations of fungicides and enzymes breaking down cell walls of yeasts and filamentous fungi. The fungicides are polyene macrolides, preferably nystatin and/or natamycin. The cell wall degrading enzymes are preferably used in combinations. They include cellulases, chitinases, mannanases, proteases and the like. The use of compositions according to the invention in the field of crop protection, especially for protection of flower bulbs, is also disclosed.
Patent AU-3338100-A (AU)
Title: Disk motor
Inventor: NOBLE ERNEST JOHN
IPC: H02K3/12
Filed: 2000-03-23
Abstract: A discoidal brushless DC motor having a stator (507) carrying windings (503) arranged in slots which radiate out from the center of the stator to the periphery. The depth of each slot increases towards the center of the stator. The slot, therefore, is wider (from side to side) and shallower towards the periphery of the stator, and narrower (from side to side) and deeper towards the center of the stator. This arrangement ensures that the windings are contained below the surface (504) of the stator (507). The magnetic circuit includes a backing of a ferromagnetic material (509). This ferromagnetic material (509) can be a watch spring core made from a long strip of soft iron tape.
Patent AU-3343995-A (AU)
Title: Use of substituted 6-amino-4h-pyrans
Inventor: URBAHNS KLAUS
IPC: A61P25/28
Filed: 1995-08-10
Abstract: PCT No. PCT/EP95/03168 Sec. 371 Date Feb. 14, 1997 Sec. 102(e) Date Feb. 14, 1997 PCT Filed Aug. 10, 1995 PCT Pub. No. WO96/06091 PCT Pub. Date Feb. 29, 1996The invention relates to the use of substituted 6-amino-4H-pyrans for the production of medicaments for the treatment of cerebral disorders, in particular of degenerative disorders such as dementia, and also for treatment of depressions and psychoses. New active compounds are prepared by reaction of the corresponding ylidene compounds with malononitrile.
Patent AU-3434593-A (AU)
Title: Method and apparatus for controlling a press
Inventor: O'BRIEN MICHAEL J
IPC: B30B15/00
Filed: 1993-01-07
Abstract: A process controller disposed to monitor and control a press. The controller monitors an appropriate variable at the press representative of the force produced at the workpiece upon which the press is operating, and compares this force to historical force data associated with the position at which the force was sampled. The historical data is stored in the form of control arrays, where the control arrays are calculated based upon one or more signature arrays stored during satisfactory press operations upon a similar workpiece. The calculation of the control arrays takes into account the deviations in the variables monitored at the press, which may include force and position. While monitoring the press based upon the HIGH and LOW control arrays, each force value is compared to the values in the HIGH and LOW control arrays at the time of sampling. The press controller is configured to monitor and control a high speed press and provides control functions during the particular press cycle in which unacceptable sample is taken.
Patent AU-3798889-A (AU)
Title: Polyolefin films having improved barrier properties
Inventor: YEH GENE H
IPC: C08J5/18
Filed: 1989-07-10
Abstract: The barrier properties of crystalline polyolefin film can be improved substantially by incorporating a precise amount of a partially incompatible wax into the polyolefin. When the polyolefin is polypropylene or polybutylene, the wax is preferably a paraffin wax. The precise amount of wax, which produces optimum improvement in barrier properties, lies in the range of about 3 to 10 percent based on the weight of the polyolefin. The range in which excellent results are obtained can be broadened by contacting the film with a cooling medium immediately after it is extruded. The film may be annealed to further improve the barrier properties.